Health
More on Health
Washington, DC – Congresswoman Diana DeGette (D-CO), co-chair of the Congressional Pro-Choice Caucus, was joined today by a group of congressional and women’s health leaders to discuss threats facing women under a Trump Administration and Republican Congress, especially a repeal of the Affordable Care Act (ACA).
Washington, DC – Congresswoman Diana DeGette (D-CO) and more than 100 other House Democrats joined forces to call on President-Elect Donald Trump to abandon the ban on women’s reproductive health choices known as the Hyde Amendment and to remove related funding constraints.
The ban, which anti-choice members of Congress have inserted into annual spending legislation for four decades, prohibits federal funds in Medicaid and other health programs from being used for abortion. This restriction on millions of women’s health care has predominantly hurt the under-privileged.
The Cures Act, formally known as H.R. 34 or the 21st Century Cures Act,1 passed overwhelmingly in the U.S. House of Representatives and Senate in the waning days of the 114th Congress and was signed into law by President Barack Obama on December 13, 2016. Weighing in at nearly 1000 pages, this bipartisan bill is the product of years of hard work by Republican and Democratic lawmakers, in collaboration with a broad array of diverse stakeholders.
WASHINGTON, DC — Representatives Diana DeGette (D-CO), Louise Slaughter (D-NY), and Frank Pallone (D-NJ) today hailed the Obama Administration’s final rule barring states from withholding federal family planning funds in a discriminatory manner from clinics that provide women’s reproductive health services. They noted that the rule issued today will shore up efforts across the country to safeguard women’s access to services protected under Title X, which have been in place for more than 25 years.
Congratulations are due to Congresswoman Diana DeGette and a bipartisan team of lawmakers who managed what seems increasingly difficult in these days of hyper-partisanship and Washington gridlock: passage of a major bill full of promise for the American people.
President Barack Obama is expected to sign the 21st Century Cures Act, which received massive support in both the House and Senate in recent days, after years of work on the part of DeGette, the Denver Democrat, and Republican Congressman Fred Upton of Michigan.
President Obama has just signed the 21st Century Cures Act into law. This landmark legislation makes significant investments in biomedical research. It will lead to new treatments for some of the most vexing medical challenges, including diseases that touch many Americans, such as Alzheimer’s and cancer.
WASHINGTON — With self-congratulatory zeal and smiles all around, huge bipartisan majorities in Congress have just passed legislation to speed the discovery of cures for killer diseases. At the same time, Republican leaders have been devising a strategy to undo the Affordable Care Act, which has done more than any law in a generation to treat people with those diseases.
“It is a real contradiction,” said Dr. Otis W. Brawley, the chief medical officer at the American Cancer Society.
To watch Congresswoman DeGette's floor speech on 21st Century Cures, click on the image above.
Washington, D.C. – U.S. Reps. Diana DeGette (CO-01) and Louise Slaughter (NY-25), co-chairs of the House Pro-Choice Caucus, called on congressional leaders to disband the Select Panel ahead of a vote expected Thursday on a privileged resolution that would provide an additional $800,000 in taxpayer dollars for the panel, which has aggressively targeted women’s health providers and the scientific community. House Republicans are now on course to spend more than $1.5 million funding this partisan attack on women’s health.
WASHINGTON, DC – Vital innovations in biomedical research are within reach, potentially saving countless lives, with the House about to debate its final version of the bipartisan 21st Century Cures Act, Congresswoman Diana DeGette (D-CO) said.
“This is a watershed moment for patients, their loved ones and health care professionals across the United States,” DeGette said. “We’re bringing hope to millions of people suffering from cancer, Alzheimer’s disease, diabetes and a host of other ailments.”